IJCRR - 7(21), November, 2015
PHYSIOTHERAPY FOR INTERMITTENT CLAUDICATION: A REVIEW ARTICLE
Author: Preeti S. Christian
Peripheral arterial disease (PAD) mainly occurs due to atherosclerotic stenosis or occlusion of the arteries of the lower limbs, resulting in an impairment of blood flow to the legs. Patients with PAD have a significant reduction in their physical activities like walking due to intermittent claudication. Intermittent claudication is a major symptom of Peripheral arterial disease. It is cramping pain, aggravated by exercise and relieved by rest. It is because of atherosclerosis, fatty deposits blocking blood flow through the arteries, which reduce blood flow to the muscles of leg. Treatments include stopping smoking, starting to physiotherapy, drugs
and surgery. This review of article found that physiotherapy can relieve intermittent claudication for many people. Exercise may be better than angioplasty. Some other types of surgeries are available which are more effective than exercise, but they carry more risks. Nowadays various modes of physiotherapy are available. It is advisable to start physiotherapy treatment with proper guidance.
Keywords: Intermittent claudication, Peripheral arterial disease, Atherosclerosis, Physiotherapy.
Preeti S. Christian. PHYSIOTHERAPY FOR INTERMITTENT CLAUDICATION: A REVIEW ARTICLE International Journal of Current Research and Review. 7(21), November, 19-24
1. Leng GC, Fowler B, Ernst E Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database of Systematic Reviews 2000;2. Art. No: CD000990. DOI: 10.1002/14651858.CD000990.
2. Edward b jude. Intermittent claudication in the patient with diabetes. Br J Diabetes Vasc Dis 2004; 4:238–42.
3. Aspi F.Golwala. Medicine for Students. In: Cardiovascular System. 22nd ed.Mumbai: Neel Graphics; 2008. p.320
4. ACSM’s Exercise Management for Persons with Chronic Diseases and Disabilities.3rd Edition. Human Kinetics; 2009.
5. Brass EP, Hiatt WR. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc Med. 2000; 5:55–59.
6. American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription. 8th ed. Philadelphia, PA: Wolters Kluwer/Lippincott Williams and Wilkins; 2010
7. American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. Champaign. IL:Human Kinetics; 2004.
8. Prior BM, Lloyd PG, Ren J, Li H, Yang HT, Laughlin MH et al. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am J Physiol. 2004; 287:H2434–H2447.
9. Yang HT, Dinn RF, Terjung RL. Training increases muscle blood flow in rats with peripheral arterial insufficiency. J Appl Physiol. 1990;69: 1353–1359.
10. Yang HT, Ren J, Laughlin MH, Terjung RL. Prior exercise train-ing produces NO-dependent increases in collateral blood flow after acute arterial occlusion. Am J Physiol.2002;282:H301– H310.
11. Yang HT, Prior BM, Lloyd PG, Taylor JC, Li Z, Laughlin MH et al. Training-induced vascular adaptations to ischemic muscle. J Physiol Pharmacol. 2008;59 suppl 7:57–70.
12. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am J Physiol. 2001;281: H2528–H2538.
13. Yang HT, Ogilvie RW, Terjung RL. Training increases collateral dependent muscle blood flow in aged rats. Am J Physiol. 1995;268:H1174–H1180.
14. Yu J, demuinck ED, Zhuang Z, Drinane M, Kauser K, Rubanyi GM et al. Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A. 2005;102:10999 –11004.
15. Gordon MB, Jain R, Beckman JA, Creager MA. The contribution of Nitric oxide to exercise hyperemia in the human forearm. Vasc Med. 2002;7:163–168.
16. Meredith IT, Currie KE, Anderson TJ, Roddy MA, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium derived nitric oxide. Am J Physiol. 1996;270:H1435–H1440.
17. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001;87:324 –329.
18. Mcdermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009;301:165– 174.
19. Bauer TA, Brass EP, Hiatt WR. Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg. 2004;40:488–493.
20. Bauer TA, Brass EP, Barstow TJ, Hiatt WR. Skeletal muscle sto2 Kinetics are slowed during low work rate calf exercise in peripheral Arterial disease. Eur J Appl Physiol. 2007;100:143–151.
21. Mcdermott MM, Hoff F, Ferrucci L, Pearce WH, Guralnik JM, Tian L et al. Lower extremity Ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease. J Am Geriatr Soc. 2007;55:400–406.
22. Askew CD, Green S, Walker PJ, Kerr GK, Green AA, Williams AD et al. Skeletal muscle phenotype is associated with exercise Tolerance in patients with peripheral arterial disease. J Vasc Surg. 2005;41:802– 807.
23. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP. Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol. 1996;81:780 –788.
24. Chinsomboon J, Ruas J, Gupta RK, Thom R, Shoag J, Rowe GC et al. The transcriptional coactivator PGC-1alpha mediates exercise-induced angiogenesis in skeletal muscle. Proc Natl Acad Sci U S A. 2009;106:21401–21406.
25. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial Disease. Circulation. 1990;81:602– 609.
26. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic Atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine,lipoprotein and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481–2485.
27. Pradhan AD, Shrivastava S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation. 2008;117:823– 831.
28. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as Predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005;112:976 –983.
29. Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Pearce WH et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: A cohort study. Ann Intern Med. 2008;148:85–93.
30. Beckman JA, Preis O, Ridker PM, Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005;96:1374–1378.
31. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol. 2005;45:1563–1569.
32. Turton EP, Coughlin PA, Kester RC, Scott DJ. Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg. 2002;23:309 –316.
33. Nielsen SL, Gyntelberg F, Larsen B, Lassen NA. Hospital versus home training, a clinical trial. Aktuelle Prob Angiol.1975; 30: 121–126.
34. Nielsen SL, Larsen B, Prahl M, Jensen CT, Jensen BE, Wenkens V. Hospital training compared with home training in patients with intermittent claudication. Ugeskr Laeger. 1977; 139: 2733–2736.
35. Patterson RB, Pinto B, Marcus B, Colucci A, Braun T, Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg.1997; 25: 312–318.
36. Cheetham DR, Burgess L, Ellis M, Williams A, Greenhalgh RM, Davies AH. Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial. Eur J Vasc Endovasc Surg.2004; 27: 17–23.
37. Regensteiner JG, Meyer TJ, Krupski WC, Cranford LS, Hiatt WR. Hospital vs home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997; 48: 291–300.
38. Bess Fowler, Konrad Jamrozik, Paul Norman, Yvonne Allen, Eve Wilkinson. Improving maximum walking distance in early peripheral Arterial disease: Randomised controlled trial. Australian Journal of Physiotherapy.2002;48.
39. Bendermacher BLW, Willigendael EM, Teijink JAW, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006.
40. Walker RD, Nawaz S, Wilkonson CH, Saxton JM, Pockley AG, Woods HF. Influence of upper- and lower-limb Exercise training on cardiovascular function and walking distances in patients with intermittent claudication. J Vasc Surg. 2000; 31: 662–669.
41. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45:S5–S67.
42. Hirsch AT, Haskal ZJ, Hertzer NR,et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol. 2006;47:1239–1312.
43. Bianca L Bendermacher, Edith M Willigendae, Saskia P Nicolaï,Lotte M Kruidenier, Rob J Welten, Erik Hendriks et al.Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based. J Vasc Surg. 2007 Jun;45(6):1192-6.
44. Gardner AW, Montgomery PS, Flinn WR, Katzel L. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg. 2005 Oct;42(4):702-9.
45. Irena Zwierska, Richard D. Walker, Sohail A. Choksy, Jonathan S. Male, A. Graham Pockley, John M. Saxton. Upper- vs lowerlimb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: A randomized controlled trial. J Vasc Surg. 2005 Dec;42(6):1122-30.
46. Sanderson B, Askew C, Stewart I, Walker P, Gibbs H, Green S. Short-term effects of cycle and treadmill training on exercise tolerance in peripheral arterial disease. J. Vasc. Surg. 2006 Jul;44(1):119-27.
47. Naomi M. Hamburg, MD; Gary J. Balady, MD. Exercise Rehabilitation in Peripheral Artery Disease Functional Impact and Mechanisms of Benefits. Circulation. 2011; 123:87-97.